Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Return on Assets (2016 - 2025)

Protalix BioTherapeutics has reported Return on Assets over the past 14 years, most recently at 0.03% for Q4 2025.

  • Quarterly results put Return on Assets at 0.03% for Q4 2025, down 14.0% from a year ago — trailing twelve months through Dec 2025 was 0.03% (down 14.0% YoY), and the annual figure for FY2025 was 0.03%, down 12.0%.
  • Return on Assets for Q4 2025 was 0.03% at Protalix BioTherapeutics, down from 0.13% in the prior quarter.
  • Over the last five years, Return on Assets for PLX hit a ceiling of 0.15% in Q2 2025 and a floor of 0.36% in Q4 2021.
  • Median Return on Assets over the past 5 years was 0.19% (2021), compared with a mean of 0.12%.
  • Biggest five-year swings in Return on Assets: crashed -42bps in 2024 and later soared 45bps in 2025.
  • Protalix BioTherapeutics' Return on Assets stood at 0.36% in 2021, then increased by 29bps to 0.26% in 2022, then skyrocketed by 81bps to 0.05% in 2023, then soared by 333bps to 0.11% in 2024, then crashed by -123bps to 0.03% in 2025.
  • The last three reported values for Return on Assets were 0.03% (Q4 2025), 0.13% (Q3 2025), and 0.15% (Q2 2025) per Business Quant data.